Zhejiang Shengda Pharm (603079) — Strategic Asset Allocation Index
Zhejiang Shengda Pharm (603079) has a Strategic Asset Allocation Index of 46.9% as of June 2023. Strategic assets (PP&E of CN¥620.12 Million plus long-term investments of CN¥-) total CN¥620.12 Million, measured against net assets of CN¥1.32 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Zhejiang Shengda Pharm Strategic Asset Allocation Index (2012–2021)
This chart shows how Zhejiang Shengda Pharm's Strategic Asset Allocation Index has evolved across 10 annual periods from 2012 to 2021. As of June 2023, the index stands at 46.9%, representing strategic assets of CN¥620.12 Million against net assets of CN¥1.32 Billion CNY. Explore Zhejiang Shengda Pharm cash conversion from operations to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Zhejiang Shengda Pharm (2012–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Zhejiang Shengda Pharm from 2012 to 2021, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 603079 stock market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 43.4% | CN¥579.96 Million | CN¥579.96 Million | CN¥- | CN¥1.34 Billion | ▼ -0.1 pp |
| 2020 | 43.5% | CN¥576.02 Million | CN¥576.02 Million | CN¥- | CN¥1.33 Billion | ▼ -19.9 pp |
| 2019 | 63.4% | CN¥577.89 Million | CN¥577.89 Million | CN¥- | CN¥911.71 Million | ▲ +5.6 pp |
| 2018 | 57.8% | CN¥479.00 Million | CN¥479.00 Million | CN¥- | CN¥828.42 Million | ▲ +27.2 pp |
| 2017 | 30.6% | CN¥235.23 Million | CN¥235.23 Million | CN¥- | CN¥768.71 Million | ▼ -20.7 pp |
| 2016 | 51.3% | CN¥225.93 Million | CN¥225.93 Million | CN¥- | CN¥440.02 Million | ▲ +7.8 pp |
| 2015 | 43.6% | CN¥191.40 Million | CN¥191.40 Million | CN¥- | CN¥439.09 Million | ▼ -3.3 pp |
| 2014 | 46.9% | CN¥152.43 Million | CN¥152.43 Million | CN¥- | CN¥324.87 Million | ▼ -7.5 pp |
| 2013 | 54.4% | CN¥152.95 Million | CN¥152.95 Million | CN¥- | CN¥281.09 Million | ▼ -20.3 pp |
| 2012 | 74.7% | CN¥138.96 Million | CN¥138.96 Million | CN¥- | CN¥185.99 Million | — |